Therapy of multiple sclerosis
Kesselring, J.
Schweizerische Medizinische Wochenschrift 114(35): 1186-1190
1984
ISSN/ISBN: 0036-7672 PMID: 6091263 Document Number: 237113
The present position on treatment of multiple sclerosis, which is to attempt to modify the course of the disease, has not produced satisfactory results to date. Hence there is all the more reason for making assiduous efforts to relieve symptoms, prevent complications and ameliorate the social, economic and psychological consequences of the disease.
Document emailed within 1 workday
Related Documents
Schanke, A.K.; Grimsmo, J.; Sundet, K. 1995: Multiple sclerosis and prerequisites for driver's licence. A retrospective study of 33 patients with multiple sclerosis assessed at Sunnaas hospital Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(11): 1349-1352Bykova, O.V.; Nankina, I.A.; Platonova, A.N.; Karpacheva, N.G.; Petrova, O.A.; Gorina, T.P.; Batysheva, T.T.; Serkov, S.V.; Kuzenkova, L.M. 2013: Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(10 Pt 2): 61-68
Laosanguanek, N.; Wiroteurairuang, T.; Siritho, S.; Prayoonwiwat, N. 2011: Reliability of the Thai version of SF-36 questionnaire for an evaluation of quality of life in multiple sclerosis patients in multiple sclerosis clinic at Siriraj Hospital Journal of the Medical Association of Thailand 94 Suppl. 1: S84-S88
Reclos, G.J.; Baxevanis, C.N.; Sfagos, C.; Papageorgiou, C.; Tsokos, G.C.; Papamichail, M. 1987: Multiple sclerosis: II. Effects of prothymosin alpha on the autologous and allogeneic MLR in patients with multiple sclerosis Clinical and Experimental Immunology 70(2): 336-344
Simó, M. 2009: Therapy of multiple sclerosis Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet Lapja 11(1): 23-26
Saida, T. 2004: Multiple sclerosis: treatment and prevention of relapses and progression in multiple sclerosis Rinsho Shinkeigaku 44(11): 796-798
Vass, K.; Schmied, M. 1996: Current therapy of multiple sclerosis Wiener Medizinische Wochenschrift 146(19-20): 514-519
Salvatores, U.; Majeron, M.; Mascetti, A. 1972: Cyclophosphamide in the therapy of multiple sclerosis Rivista Sperimentale di Freniatria e Medicina Legale Delle Alienazioni Mentali 96(1): 163-184
Pallotta, R. 1982: Hyperbaric therapy of multiple sclerosis Minerva Medica 73(42): 2947-2954
Nouza, K.; Krejcová, H. 1997: Pathogenesis and therapy of multiple sclerosis Bratislavske Lekarske Listy 98(4): 199-203
Csépány, T.ün.; Bereczki, D.án. 2004: Immunomodulatory therapy in multiple sclerosis Ideggyogyaszati Szemle 57(11-12): 401-416
Veĭn, A.M.; Smirnov, I.K. 1983: Pathogenetic therapy of multiple sclerosis Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 83(2): 181-185
Le Page, E.; Edan, G. 2006: Drug therapy in multiple sclerosis La Revue du Praticien 56(12): 1336-1346
Reichel, D.; Kölmel, H.W. 1995: Multiple sclerosis--current status of therapy Zeitschrift für Arztliche Fortbildung 89(2): 151-158
Hohlfeld, R. 1999: Immunological basis for the therapy of multiple sclerosis Acta Neurologica Belgica 99(1): 40-43
Benesova, Y.; Stourac, P.; Beranek, M.; Kadanka, Z. 2005: Mitoxantrone therapy in rapidly worsening multiple sclerosis Bratislavske Lekarske Listy 106(3): 141-143
Rodgers, D.; Khoo, K.; MacEachen, M.; Oven, M.; Beatty, W.W. 1996: Cognitive therapy for multiple sclerosis: a preliminary study Alternative Therapies in Health and Medicine 2(5): 70-74
Schmidt, S.; Hohlfeld, R. 1995: Current therapy of multiple sclerosis: are there indications for intravenous immunoglobulins? Der Nervenarzt 66(4): 304-307
Savin, A.A.; Karlov, V.A.; Seleznev, A.N.; Kozlov, S.A.; Kitaeva, L.V. 1995: Russian preparations for the metabolic therapy of multiple sclerosis patients Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 95(2): 37-40
Rieckmann, P. 2001: Early multiple sclerosis therapy in the effects of public health economics Medizinische Klinik 96(Suppl 1): 17-21